EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Metabolic Liver Disease and Obesity at a Therapeutic Crossroads: From Lifestyle Interventions to Incretin-based Pharmacotherapy

Demosthenes Panagiotakos

Journal of Atherosclerosis Prevention and Treatment · 2025

DOI: 10.4103/aptj.aptj_26_26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Atherosclerosis Prevention and Treatment, 2025. Verfasst von Demosthenes Panagiotakos. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Panagiotakos, D. (2025). Metabolic Liver Disease and Obesity at a Therapeutic Crossroads: From Lifestyle Interventions to Incretin-based Pharmacotherapy. Journal of Atherosclerosis Prevention and Treatment. https://doi.org/10.4103/aptj.aptj_26_26

Vancouver

Panagiotakos D. Metabolic Liver Disease and Obesity at a Therapeutic Crossroads: From Lifestyle Interventions to Incretin-based Pharmacotherapy. Journal of Atherosclerosis Prevention and Treatment. 2025. doi:10.4103/aptj.aptj_26_26

BibTeX
@article{Panagiotakos2025,
  author = {Panagiotakos, Demosthenes},
  title = {Metabolic Liver Disease and Obesity at a Therapeutic Crossroads: From Lifestyle Interventions to Incretin-based Pharmacotherapy},
  journal = {Journal of Atherosclerosis Prevention and Treatment},
  year = {2025},
  doi = {10.4103/aptj.aptj_26_26}
}
Kostenlos starten →